Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvant.

Simple item page
dc.contributor.authorVásquez, A.
dc.contributor.authorAvila Véliz, Anastasia Vanessa
dc.contributor.authorBruce Castillo, Loreto
dc.contributor.authorHarris D., Paul R.
dc.date.accessioned2016-05-10T18:10:38Z
dc.date.available2016-05-10T18:10:38Z
dc.date.issued2015
dc.identifier.issn2164-5515
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/12867
dc.language.isoen
dc.relation.isformatofHuman Vaccines and Immunotherapuetics No. 3 (11), p. 776-788.
dc.revistaHUMAN VACCINES & IMMUNOTHERAPEUTICSes_ES
dc.rightsacceso restringido
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherAnticuerpos bacterianoses_ES
dc.subject.otherHelicobacter pylori - Inmunologíaes_ES
dc.subject.otherPorinases_ES
dc.subject.otherInmunoglobulinases_ES
dc.titleOral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvant.es_ES
dc.typeartículo
sipa.codpersvinculados1000159
sipa.codpersvinculados80706
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
1083.pdf
Size:
587.04 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas